Literature DB >> 25261574

Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype.

Muhammad Haroon1, Robert Winchester2, Jon T Giles2, Eric Heffernan3, Oliver FitzGerald1.   

Abstract

OBJECTIVES: Psoriatic arthritis (PsA) susceptibility is associated with several different class I alleles, suggesting separate patterns of MHC effect. This exploratory study was based on the hypothesis that heterogeneity of the clinical phenotype of PsA might be explained by differing associations of clinical features with these susceptibility genes.
METHODS: The clinical phenotype of 282 PsA patients in a cohort previously studied for associations with human leukocyte antigen (HLA)-B and HLA-C genotypes was first preliminarily assessed by univariate associations of susceptibility genes with specific clinical characteristics. To explore the potential genotypic effects of pairwise combinations of different HLA-B and C alleles/haplotypes, we created a series of allele/haplotype risk scores combining single alleles/haplotypes separately associated with being in the highest PsA severity propensity tertile based on the features studied by univariate analysis.
RESULTS: In exploratory univariate analyses, B*27:05:02 was positively associated with enthesitis, dactylitis and symmetric sacroiliitis, whereas B*08:01:01-C*07:01:01and its component alleles were positively associated with joint fusion and deformities, asymmetrical sacroiliitis, and dactylitis. HLA-C*06:02:01 was negatively associated with asymmetrical sacroiliitis. The highest propensity score for severe PsA was with B*27:05:02-C*02:02:02, B*08:01:01-C*07:01:01 and B*37:01:01-C*06:02:01, but not the B*27:05:02-C*01:01:01 or B*57:01:01-C*06:02:01 haplotypes. In contrast, B*44 haplotypes were associated with presence of milder disease, and in univariate analysis with a decreased frequency of enthesitis, joint fusion, deformities and dactylitis.
CONCLUSIONS: Different HLA susceptibility genes were associated with particular features that defined the PsA phenotype of a given patient. Additive interactions between different susceptibility HLA alleles defined the propensity for a more severe or milder musculoskeletal phenotype. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Gene Polymorphism; Inflammation; Psoriatic Arthritis

Mesh:

Substances:

Year:  2014        PMID: 25261574     DOI: 10.1136/annrheumdis-2014-205461

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

Review 1.  Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.

Authors:  Amy S Kehl; Maripat Corr; Michael H Weisman
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

Review 2.  Why location matters - site-specific factors in rheumatic diseases.

Authors:  Caroline Ospelt; Mojca Frank-Bertoncelj
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 3.  Current concepts and unmet needs in psoriatic arthritis.

Authors:  Farrouq Mahmood; Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2017-11-13       Impact factor: 2.980

Review 4.  The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

Review 5.  Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis.

Authors:  Akihiro Nakamura; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

Review 6.  Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.

Authors:  Angela McArdle; Stephen Pennington; Oliver FitzGerald
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 7.  Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis.

Authors:  L E Durham; B W Kirkham; L S Taams
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

Review 8.  Psoriatic arthritis from a mechanistic perspective.

Authors:  Georg Schett; Proton Rahman; Christopher Ritchlin; Iain B McInnes; Dirk Elewaut; Jose U Scher
Journal:  Nat Rev Rheumatol       Date:  2022-05-05       Impact factor: 20.543

9.  Implications of the diversity of class I HLA associations in psoriatic arthritis.

Authors:  Robert Winchester; Jon Giles; Deepak Jadon; Muhammed Haroon; Neil McHugh; Oliver FitzGerald
Journal:  Clin Immunol       Date:  2016-07-25       Impact factor: 3.969

Review 10.  Pathophysiology, assessment and treatment of psoriatic dactylitis.

Authors:  Dennis McGonagle; Ai Lyn Tan; Abdulla Watad; Philip Helliwell
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.